journal article·2025-02-12Open access

Hyaluronic Acid-Coated SPIONs with Attached Folic Acid as Potential T2 MRI Contrasts for Anticancer Therapies

Martyna Kasprzyk, Gabriela Opiła, Alicja Hinz, Sylwia Stankiewicz, Monika Bzowska, Karol Wolski, Joanna Dulińska-Litewka, Janusz Przewoźnik, Czesław Kapusta, Anna Karewicz

Abstract

High Resolution Image Download MS PowerPoint Slide Superparamagnetic iron oxide nanoparticles (SPIONs) are known to be good MRI contrasts, but they have a high tendency to aggregate and their biocompatibility is limited. Hyaluronic acid is highly biocompatible, can provide SPION with colloidal stability, and interacts specifically with tumor cells through the CD44 receptor; therefore, it was used as a stabilizing layer. We successfully obtained SPION coated with hyaluronic acid and further functionalized it with folic acid to construct a dual-targeted system. The physicochemical properties of the nanoparticles were investigated using DLS/ELS, AFM, XRD, and ATR-FTIR. Their magnetic characterization was performed by magnetometry, Mössbauer spectroscopy, 1 H NMR T1 and T2 measurements, and MRI. The nanoparticles’ biocompatibility was verified on blood and hepatocytes, and their cytotoxicity was tested on glioma and adenocarcinoma cells using the MTT assay. The nanoparticles were spherical, colloidally stable, and had low dispersity. Their cores were formed by 7 nm crystallites of magnetite in its oxidized form, maghemite. Our SPIONs were superparamagnetic and could potentially serve as effective T2 contrasts for MRI. The performance of SPIONs modified with folic acid was superior to that observed for commercial contrasts. Our nanoparticles were also hemocompatible and were efficiently taken up by glioblastoma cancer cells. Folic acid-modified SPIONs could also reduce viability of tumor cells in a dose-dependent manner. Thus, the proposed system has potential application as both a diagnostic tool and a therapeutic agent for targeted anticancer therapies.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced MRI Techniques and Applications · Lanthanide and Transition Metal Complexes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Kraków, Poland

Doctoral School of Exact and Natural Sciences, Jagiellonian University, Prof. S. Łojasiewicza 11, 30-348 Kraków, Poland

Faculty of Physics and Applied Computer Science, AGH University of Kraków, Al. A. Mickiewicza 30, 30-059 Kraków, Poland

Department of Cell Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Kraków, Poland

Chair of Medical Biochemistry, Jagiellonian University Medical College, Kopernika 7, 31-034 Kraków, Poland

Funding

European Commission · Narodowe Centrum Nauki · Uniwersytet Jagiellonski w Krakowie · AGH University of Krakow

References (61)

Show source-provided references
1. 10.1002/cnr2.176410.1002/cnr2.1764 ↗
2. 10.1186/s40644-023-00557-810.1186/s40644-023-00557-8 ↗
3. 10.1016/j.procs.2023.01.05110.1016/j.procs.2023.01.051 ↗
4. 10.3390/cancers1503095010.3390/cancers15030950 ↗
5. 10.3390/cancers1410253910.3390/cancers14102539 ↗
6. 10.1007/s00062-020-00882-610.1007/s00062-020-00882-6 ↗
7. 10.3390/ma1211179310.3390/ma12111793 ↗
8. 10.1007/s00330010090810.1007/s003300100908 ↗
9. 10.1016/j.biomaterials.2009.02.02310.1016/j.biomaterials.2009.02.023 ↗
10. 10.3390/ma1204061710.3390/ma12040617 ↗
11. 10.1016/j.jmmm.2005.10.11210.1016/j.jmmm.2005.10.112 ↗
12. 10.1080/21691401.2019.170985510.1080/21691401.2019.1709855 ↗
13. 10.1016/j.jbc.2021.10054910.1016/j.jbc.2021.100549 ↗
14. 10.1021/acs.molpharmaceut.9b0008310.1021/acs.molpharmaceut.9b00083 ↗
15. 10.1023/a:102642551949710.1023/a:1026425519497 ↗
16. 10.3390/cancers1204094010.3390/cancers12040940 ↗
17. 10.1016/j.carbpol.2015.06.01010.1016/j.carbpol.2015.06.010 ↗
18. 10.1016/j.biomaterials.2014.01.01110.1016/j.biomaterials.2014.01.011 ↗
19. 10.1016/j.colsurfb.2016.11.00310.1016/j.colsurfb.2016.11.003 ↗
20. 10.3389/fphar.2022.91881910.3389/fphar.2022.918819 ↗
21. 10.1016/j.carbpol.2020.11613010.1016/j.carbpol.2020.116130 ↗
22. 10.1021/acsomega.0c0550010.1021/acsomega.0c05500 ↗
23. 10.3390/biom904015410.3390/biom9040154 ↗
24. 10.1007/s11051-012-1372-910.1007/s11051-012-1372-9 ↗
25. 10.2147/IJN.S16535910.2147/IJN.S165359 ↗
26. 10.1016/j.jcis.2016.11.09710.1016/j.jcis.2016.11.097 ↗
27. 10.2147/IJN.S32435410.2147/IJN.S324354 ↗
28. 10.1142/S179329201450069610.1142/S1793292014500696 ↗
29. 10.1016/j.biomaterials.2008.07.00410.1016/j.biomaterials.2008.07.004 ↗
30. 10.1021/nl080561510.1021/nl0805615 ↗
31. 10.1021/acsami.2c1315610.1021/acsami.2c13156 ↗
32. 10.3390/molecules2403061710.3390/molecules24030617 ↗
33. 10.3390/polym1208180010.3390/polym12081800 ↗
34. 10.1016/0003-9861(88)90153-110.1016/0003-9861(88)90153-1 ↗
35. 10.1021/acs.macromol.0c0174210.1021/acs.macromol.0c01742 ↗
36. 10.3390/magnetochemistry808009010.3390/magnetochemistry8080090 ↗
37. 10.3390/ma1112238810.3390/ma11122388 ↗
38. 10.1007/s10853-019-03667-610.1007/s10853-019-03667-6 ↗
39. 10.3390/biom1008118510.3390/biom10081185 ↗
40. 10.1515/epoly-2022-008610.1515/epoly-2022-0086 ↗
41. 10.1038/s41598-023-37826-210.1038/s41598-023-37826-2 ↗
42. 10.1007/s11051-014-2678-610.1007/s11051-014-2678-6 ↗
43. 10.1038/nature1232710.1038/nature12327 ↗
44. 10.1016/j.eurpolymj.2019.01.03010.1016/j.eurpolymj.2019.01.030 ↗
45. 10.1007/s11095-008-9697-x10.1007/s11095-008-9697-x ↗
46. 10.1016/j.brainresbull.2020.03.01810.1016/j.brainresbull.2020.03.018 ↗
47. 10.3390/gels912094410.3390/gels9120944 ↗
48. 10.1016/j.jmbbm.2019.05.00110.1016/j.jmbbm.2019.05.001 ↗
49. 10.21873/anticanres.1601310.21873/anticanres.16013 ↗
50. 10.1038/s41598-023-49072-710.1038/s41598-023-49072-7 ↗
51. 10.1186/s12906-023-04212-410.1186/s12906-023-04212-4 ↗
52. 10.1021/acs.biomac.1c0065310.1021/acs.biomac.1c00653 ↗
53. 10.3390/ph1402010110.3390/ph14020101 ↗
54. 10.1016/j.nucmedbio.2007.12.00810.1016/j.nucmedbio.2007.12.008 ↗
55. 10.1242/bio.04167310.1242/bio.041673 ↗
56. 10.1186/s40580-021-00260-z10.1186/s40580-021-00260-z ↗
57. 10.1038/s41420-022-01297-710.1038/s41420-022-01297-7 ↗
58. 10.1186/s40164-023-00427-w10.1186/s40164-023-00427-w ↗
59. 10.1038/s41392-023-01606-110.1038/s41392-023-01606-1 ↗
60. 10.3390/pharmaceutics1501023610.3390/pharmaceutics15010236 ↗
61. 10.1039/D0NR00765J10.1039/D0NR00765J ↗